• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC-S 40 REFOB BN CMT R; BONE CEMENT, ANTIBIOTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC-S 40 REFOB BN CMT R; BONE CEMENT, ANTIBIOTICS Back to Search Results
Catalog Number 4710500394-1
Device Problem Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Bacterial Infection (1735); Pain (1994); Osteopenia/ Osteoporosis (2651)
Event Date 06/23/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).List of associated devices: femoral component option size e right, reference (b)(4), batch 63957962.Articular surface regular constraint, reference (b)(4), batch 63952346.Poly patella standard size 35 mm diameter 9.0 mm thickness cemented, reference (b)(4), batch 63984274.Stemmed nonaugmentable tibial component option cr/ps/lps size 5 for cemented use only, reference (b)(4), batch 63905965.Report source, foreign - event occurred in (b)(6).The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported a study patient underwent a right total knee arthroplasty on (b)(6) 2018.Subsequently, tibial baseplate loosening was noted on (b)(6) 2020 and the pt is scheduled for reoperation on (b)(6) 2020.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.D11 - list of associated devices: - femoral component option size e right, reference 00595601502, batch 63957962 - articular surface regular constraint, reference 90597004010, batch 63952346 - poly patella standard size 35 mm diameter 9.0 mm thickness cemented, reference 00597206535, batch 63984274 - stemmed nonaugmentable tibial component option cr/ps/lps size 5 for cemented use only, reference 00598604701, batch 63905965.- optipac 40 refobacin bone cement r, reference 4710500394-1, batch a744b05300 the investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported a study patient underwent a right total knee arthroplasty on (b)(6) 2018.Subsequently, tibial baseplate loosening was noted on (b)(6) 2020 and the patient has been revised on (b)(6) 2020.
 
Manufacturer Narrative
(b)(4).This follow-up report is being filled to relay additional information.Received x-ray shows that all components of the knee prosthesis are loosen as mentioned in the op notes.Therefore, the reported event has been confirmed.The product analysis can't be performed as the product was not returned.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.The review of the sterilization certificate indicates that the products were sterilized according to the specification.Medical records were translated in and it was found that the revision surgery was due to an infection.A lab analysis of the samples taken during the revision surgery has been performed and showed that the infection was due to staphylococcus epidermidis that is a normal colonizer of the skin and sometimes mucosa.It was also found that 6 of 12 blood samples dated from on (b)(6) 2019 were positive to s.Epidermidis whereas the results were negative on (b)(6) 2020.The bacterial infection is the cause of the implant loosening and the revision.A complaint extract was done regarding revision due to infection, loosening and pain: 3 complaints (3 products), this one included, have been recorded on optipac 40 refobacin bone cement r, reference: 4710500394-1, from january 01, 2017 to november 23, 2020.1 complaint (1 product), this one included, has been recorded on optipac 40 refobacin bone cement r, reference: 4710500394-1, batch: a720a04010.According to available data, root cause of the event was unable to be determined.Indeed, even if the implant loosening was due to the staphylococcus epidermidis bacterial infection, it is impossible to determine the root cause of the infection.The patient blood analysis showed that the bacterial germ was present in his blood on (b)(6) 2019, but the septicaemia could have occurred for several reason.However, there is no evidence that the event is related to the product.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that a study patient underwent a right total knee arthroplasty on (b)(6) 2018.Subsequently, the patient underwent a stage 1 revision due to infection on (b)(6)2020.All components were noted to be loose and easily removed, antibiotic infused cement spacers were placed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC-S 40 REFOB BN CMT R
Type of Device
BONE CEMENT, ANTIBIOTICS
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key10501036
MDR Text Key205878837
Report Number3006946279-2020-00170
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Type of Report Initial,Followup,Followup
Report Date 11/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/28/2019
Device Catalogue Number4710500394-1
Device Lot NumberA720A04010
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASSOCIATED DEVICES LISTED IN H10.; ASSOCIATED DEVICES LISTED IN H10.; ASSOCIATED DEVICES LISTED.
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age84 YR
Patient Weight85
-
-